TetraScience – Solving humanity's grand challenges by accelerating and improving scientific outcomes

The Silicon Review

TetraScience is the Scientific Data Cloud company with a mission to accelerate scientific discovery and improve and extend human life. The Tetra Scientific Data Cloud(TM) is the only open, cloud-native platform purpose-built for science that connects lab instruments, informatics software, and data apps across the biopharma value chain and delivers the foundation of harmonized, actionable scientific data necessary to transform raw data into accelerated and improved scientific outcomes. Through the Tetra Partner Network, market-leading vendors access the power of its cloud to help customers maximize the value of their data.

The Tetra Scientific Data Cloud™ is the only open, cloud-native platform purpose-built for science and provides life sciences companies with the flexibility, scalability, and data-centric capabilities to enable easy access to centralized, harmonized, and actionable scientific data. TetraScience has built the largest integration network of lab instruments, informatics applications, analytics, and data science partners, creating seamless interoperability and an innovation feedback loop that will drive the future of life sciences and the delivery of life-saving therapeutics. Backed by Insight Partners, Alkeon Capital Management, Underscore, and Impetus Ventures, TetraScience currently counts over 100 leading pharmaceutical and biotech companies as customers.

Tetra Data Platform

Connect your entire lab by integrating your data sources and targets. Eliminate the need for fragile and costly point-to-point solutions. Automatically collect and centralize data from thousands of different instruments and applications in the cloud. Remove manual data transfer and processing, simplify data access and ensure the integrity of your data. Automatically standardize and curate data from multiple sources and formats. Automatically transform raw data into a vendor-agnostic format and harmonize the content through common taxonomies and ontologies. Eliminate the time and effort for data processing. Gain insights from your scientific data visualizing, comparing, and reusing standardized and harmonized data that are automatically updated across applications. Leverage your processed data for advanced analytics and artificial intelligence.

Platform Capabilities

Cloud-native infrastructure: Access centralized data in the cloud built upon AWS. Gain storage and processing scalability and enterprise-grade security. Leverage single sign on (SSO) and role-based user management and authentication.

Flexible data processing: Customize and configure your data processing through flexible pipelines that support your critical use cases and extend to new technologies and processes for future needs.

Powerful interface: Quickly configure and deploy new processes and technologies through a comprehensive programming API. Access, explore, and visualize your scientific data through a centralized search interface and SQL query.

End-to-end data liquidity: Span the entire scientific lifecycle from R&D through QA/QC and manufacturing to gain insights. Drive tech transfer, knowledge creation and scientific decision-making for increased productivity and faster time to market.

Tetra Partner Network

Life science vendors have contributed to radical improvements in health. Now, as the biopharmaceutical industry utilizes more advanced instruments and applications, research complexity has increased, resulting in enormous data production. As a result, there is a historical opportunity to fundamentally transform how they power biopharmaceutical innovation. The Tetra Partner Network creates unique opportunities for life science vendors to leverage the potential of this historic moment

Tetra Catalysts

The decision for a unique offering like the Tetra Scientific Data Cloud is a first step in the digital transformation journey in the scientific space. To accelerate use of the Scientific Data Cloud and maximize the value of scientific data as fast as possible, TetraScience is offering “Tetra Catalysts”. The intent and focus of Tetra Catalysts is to quickly identify and onboard the most impactful scientific use cases in order to automate end-to-end processes and increase laboratory efficiency. At the heart of Tetra Catalysts are TetraScience’s “Sciborgs” – Scientific Business Analysts and Scientific Data Architects who have both life science and technical expertise. By matching customers’ problems to be solved with the capabilities of the Tetra Scientific Data Cloud, they help you to improve and accelerate science.

GxP with the Tetra Scientific Data Cloud

The Tetra Scientific Data Cloud supports 21 CFR Part 11, Annex 11 and, GxP data integrity definitions and guidance for industry. Customers can deploy use cases in biopharma, including (but not limited to) screening, pre-clinical testing, model development, ADME-Tox, pilot plant synthesis, bioprocessing, manufacturing, and quality control / release testing with minimal efforts.

Patrick Grady, Chairman and CEO | In his own words

Prior to TetraScience, I helped pioneer several core technologies - including web services, service-oriented architectures (SOA), and software-as-a-service (SaaS) - which undergird the multi-hundred-billion-dollar B2B cloud market. I also played a pivotal role in commercializing virtual assistant/intelligent agent technology which is now ubiquitous in consumer apps such as Siri and Alexa.

Recognized as one of the leading CEOs and innovators in the B2B market on numerous occasions and was a recipient of the 2006 Fast Company award, given to the top 50 people in the world to “change the way we live and work”, for my efforts in personal agent/AI technology, joining Bill Gates and Bill Clinton among others that year.

I was the founder and CEO of Rearden Commerce, the first enterprise SaaS company and one of the most innovative and fastest growing companies of the early cloud era. By 2011, Rearden was worth $1.5B, making it the 6th most valuable privately held tech company in the world at the time. Rearden’s high-water mark was artificially capped by strategic investors who committed a number of egregious governance and commercial contract breaches which forced the company to sub-optimize and exit early.

Unimpeded by these actions, given its recurring revenue and competitive moats, Rearden today would be worth tens of billions. These breaches deeply impaired one of Silicon Valley's greatest startup cultures, leaving me more passionate than ever about building and preserving inspirational, empowering, and impactful cultures, and ensuring best-in-class governance.